Buyer · Federal
Ministry of Social Affairs and Health
Helsinki · Helsinki-Uusimaa
Total awarded
€25.8m
5 / 5 with a value
Current incumbents
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Tuberculosis (BCG) vaccine 2027-2029 (2029-2030, 2030-2031) | Ministry of Social Affairs and Health | Aj Vaccines | €529,920 | 5 Oct 2026 |
| Diphtheria and Tetanus (dT) vaccine 2027-2029 (2029-2030, 2030-2031) | Ministry of Social Affairs and Health | Aj Vaccines | €6,535,680 | 2 Oct 2026 |
| Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031) | Ministry of Social Affairs and Health | GlaxoSmithKline Oy | €2,556,000 | 25 Sept 2026 |
| Measles, mumps and rubella (MMR) vaccine 2027-2028 (2029, 2030) | Ministry of Social Affairs and Health | MSD Finland Oy | €5,097,600 | 7 Sept 2026 |
| Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) | Ministry of Social Affairs and Health | Sanofi Oy | €11,088,000 | 7 Sept 2026 |